Kestrel Group Reports Second Quarter 2026 Financial Results
Go back to Kestrel Group Reports Second Quarter 2026 Financial Results| KING PHARMACEUTICALS (NASDAQ: KG) | Delayed: 4.91 -0.33 (6.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.24 | 52 Week High | $14.26 | |||
| Open | $5.15 | 52 Week Low | $7.18 | |||
| Day High | $5.15 | P/E | 14.44 | |||
| Day Low | $4.81 | EPS | $0.34 | |||
| Volume | 12,795 | |||||



